Alpha-Synuclein Is a Cellular Ferrireductase
2011
Alpha-Synuclein as a Cellular Ferrireductase
publication
Evidence: high
Author Information
Author(s): Paul Davies, Dima Moualla, David R. Brown
Primary Institution: University of Bath
Hypothesis
Is alpha-synuclein a cellular ferrireductase responsible for reducing iron (III) to bioavailable iron (II)?
Conclusion
Alpha-synuclein functions as a ferrireductase, increasing the levels of bioavailable iron (II) in cells.
Supporting Evidence
- Alpha-synuclein was shown to reduce iron (III) to iron (II) in the presence of copper and NADH.
- Overexpression of alpha-synuclein in cells significantly increased the levels of iron (II).
- Disease-associated mutations in alpha-synuclein affected its ferrireductase activity.
Takeaway
Alpha-synuclein helps turn a type of iron that cells can't use into a type they can use, which is important for brain health.
Methodology
The study used recombinant protein assays and cellular lysates to assess ferrireductase activity and metal binding.
Limitations
The study does not explore the long-term effects of altered ferrireductase activity on neuronal health.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website